News | Cardiac Diagnostics | August 07, 2015

Boehringer Ingelheim to Sponsor ACC-Led Diabetes Collaborative Registry

Pharmaceutical company becomes latest participant in national data repository for coordinated care of diabetes patients

ACC, Boehringer Ingelheim, Diabetes Collaborative Registry, American College of Cardiology

August 7, 2015 — The American College of Cardiology (ACC) has announced that Boehringer Ingelheim is the newest industry sponsor of The Diabetes Collaborative Registry. The registry is an interdisciplinary effort led by the college in partnership with the American Diabetes Association, the American College of Physicians, the American Association of Clinical Endocrinologists and the Joslin Diabetes Center.

“Heart disease is the leading cause of death for people with diabetes,” said American College of Cardiology President Kim Allan Williams, M.D., FACC. “Their unique needs call for cross-specialty care that will be made possible through the Diabetes Collaborative Registry, and we thank Boehringer Ingelheim for joining the effort to support the continued, accelerated growth of this registry.”

Since the official launch of the Diabetes Collaborative Registry just one year ago, interest and participation in the program has exceeded expectations. To date, more than 100 cross-specialty practice entities have enrolled in the registry, expanding an already robust national footprint spanning nearly 500 practice locations with 1,300 providers across 28 states.

Additional support will allow the registry to scale up and increase its impact, including outreach to and enrollment of a larger installation base of practices and health systems, enhanced quality improvement performance reports delivered to participants, and more data collection to drive actionable insights and decision-making to improve the quality of care delivered to the right patients at the right time.

The Diabetes Collaborative Registry aspires to create the largest single repository of real-world clinical information on diabetes and cardiometabolic care in the world to improve the quality of life for all people living with these conditions.

Patients with diabetes often receive treatments across multiple medical specialties for a multitude of related conditions. The Diabetes Collaborative Registry will allow for a longitudinal study of diabetes across all stages of the disease—including presentation, progression, management and outcomes—even as patients receive treatment from multidisciplinary care teams. It will also incorporate the growing number of patients with diabetes in the ACC’s PINNACLE Registry, which is the nation’s largest ambulatory cardiovascular registry.

Participation in the registry is expected to yield long-term benefits for practices, providers and patients, as physicians can track adherence and performance against evidence-based national metrics and benchmarks at the provider, practice and site level through regular reports received; can identify potential areas to target for quality improvement opportunities; may meet requirements for federal incentive reporting programs, such as the Centers for Medicare and Medicaid Services’ Physician Quality Reporting System and Electronic Health Care Record Incentive Program; and will, ultimately, transform the quality of care provided to patients across the continuum of ambulatory primary and specialty care.

Researchers will have the opportunity to gather insights from this repository of diabetes care data from various providers in outpatient settings, and patients will benefit from their physicians’ increased access to a central repository of diabetes data based on the latest science and research that can be used to tailor their care. The registry maintains an aggressive outcomes research agenda and is anticipated to complete a number of research abstracts and manuscripts by the conclusion of this year.

For more information:

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init